Amgen Inc AMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/03/24 EDT

311.41

+0.12 (+0.04%)

Volume

150,000

311.29

+32.90 (+11.82%)

Volume

9,153,240

52 week range

211.71 - 329.72

Open313.39
Day High322.60
Day Low308.68
Prev Close278.39
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23

Key Stats

Market Cap166.968B
Shares Out536.38M
10 Day Average Volume2.54M
Dividend9.00
Dividend Yield2.89%
Beta0.58
YTD % Change8.08

KEY STATS

Open313.39
Day High322.60
Day Low308.68
Prev Close278.39
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23
Market Cap166.968B
Shares Out536.38M
10 Day Average Volume2.54M
Dividend9.00
Dividend Yield2.89%
Beta0.58
YTD % Change8.08

RATIOS/PROFITABILITY

EPS (TTM)7.00
P/E (TTM)44.48
Fwd P/E (NTM)16.02
EBITDA (TTM)10.453B
ROE (TTM)72.57%
Revenue (TTM)29.532B
Gross Margin (TTM)66.38%
Net Margin (TTM)12.74%
Debt To Equity (MRQ)1,274.79%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/16/2024
Div Amount2.25
Split Date-
Split Factor-

Latest On Amgen Inc

Stocks making the biggest moves midday: Apple, Expedia, Block and more17 Hours AgoCNBC.com
Here's what's driving Friday's stock action in Apple, Coterra and Eli Lilly18 Hours AgoCNBC.com
Amgen stock soars on weight loss drug progress as Novo Nordisk, Eli Lilly slide19 Hours AgoCNBC.com
Cramer’s Mad Dash: Amgen20 Hours AgoCNBC.com
Jim Cramer's top 10 things to watch in the stock market Friday21 Hours AgoCNBC.com

Content From Our Affiliates

BMO Capital Reaffirms Their Buy Rating on Amgen (AMGN)6 Hours AgoTipRanks
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)18 Hours AgoTipRanks
Oppenheimer Remains a Buy on Amgen (AMGN)22 Hours AgoTipRanks
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)23 Hours AgoTipRanks
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Amgen (AMGN) and Zimmer Biomet Holdings (ZBH)23 Hours AgoTipRanks

Profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin...

Robert Bradway

Chairman of the Board, President, Chief Executive Officer

Peter Griffith

Chief Financial Officer, Executive Vice President

David Reese

Executive Vice President, Chief Technology Officer

Murdo Gordon

Executive Vice President - Global Commercial Operations

Lori Johnston

Executive Vice President - Human Resources

Address

One Amgen Center Drive

Thousand Oaks, CA

91320

United States

https://www.amgen.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
PFE Pfizer Inc	27.81	+0.11	+0.40%
SNY Sanofi SA	49.01	-0.45	-0.91%
GILD Gilead Sciences Inc	64.78	-0.55	-0.84%
GSK GSK plc	43.50	+0.15	+0.35%
VRTX Vertex Pharmaceuticals Inc	401.08	+0.92	+0.23%